160 related articles for article (PubMed ID: 21838893)
1. Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway.
Somvanshi RK; Chaudhari N; Qiu X; Kumar U
J Mol Signal; 2011 Aug; 6():9. PubMed ID: 21838893
[TBL] [Abstract][Full Text] [Related]
2. Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergic receptor and somatostatin receptor-5.
Somvanshi RK; War SA; Chaudhari N; Qiu X; Kumar U
Cell Signal; 2011 May; 23(5):794-811. PubMed ID: 21238583
[TBL] [Abstract][Full Text] [Related]
3. C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling.
Somvanshi RK; Billova S; Kharmate G; Rajput PS; Kumar U
Cell Signal; 2009 Sep; 21(9):1396-414. PubMed ID: 19426801
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1.
Zou S; Somvanshi RK; Kumar U
Neuroscience; 2017 Jan; 340():218-231. PubMed ID: 27984180
[TBL] [Abstract][Full Text] [Related]
5. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC
Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405
[TBL] [Abstract][Full Text] [Related]
7. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy.
Lavoie C; Mercier JF; Salahpour A; Umapathy D; Breit A; Villeneuve LR; Zhu WZ; Xiao RP; Lakatta EG; Bouvier M; Hébert TE
J Biol Chem; 2002 Sep; 277(38):35402-10. PubMed ID: 12140284
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 1A receptor regulates β-arrestin binding of the β
Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
[TBL] [Abstract][Full Text] [Related]
9. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).
Pfeiffer M; Koch T; Schröder H; Klutzny M; Kirscht S; Kreienkamp HJ; Höllt V; Schulz S
J Biol Chem; 2001 Apr; 276(17):14027-36. PubMed ID: 11134004
[TBL] [Abstract][Full Text] [Related]
10. β2-Adrenergic Receptors Chaperone Trapped Bitter Taste Receptor 14 to the Cell Surface as a Heterodimer and Exert Unidirectional Desensitization of Taste Receptor Function.
Kim D; Pauer SH; Yong HM; An SS; Liggett SB
J Biol Chem; 2016 Aug; 291(34):17616-28. PubMed ID: 27342779
[TBL] [Abstract][Full Text] [Related]
11. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor-2 negatively regulates β-adrenergic receptor mediated Ca(2+) dependent signaling pathways in H9c2 cells.
Somvanshi RK; Zou S; Qiu X; Kumar U
Biochim Biophys Acta; 2014 Apr; 1843(4):735-45. PubMed ID: 24412308
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells--high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein.
Seifert R; Lee TW; Lam VT; Kobilka BK
Eur J Biochem; 1998 Jul; 255(2):369-82. PubMed ID: 9716378
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
Chandrasekera PC; Wan TC; Gizewski ET; Auchampach JA; Lasley RD
Cell Signal; 2013 Apr; 25(4):736-42. PubMed ID: 23291003
[TBL] [Abstract][Full Text] [Related]
15. The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors.
Grant M; Patel RC; Kumar U
J Biol Chem; 2004 Sep; 279(37):38636-43. PubMed ID: 15247250
[TBL] [Abstract][Full Text] [Related]
16. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
Biochim Biophys Acta; 2011 Jun; 1813(6):1172-89. PubMed ID: 21419811
[TBL] [Abstract][Full Text] [Related]
17. β
Galaz-Montoya M; Wright SJ; Rodriguez GJ; Lichtarge O; Wensel TG
J Biol Chem; 2017 Jun; 292(24):9967-9974. PubMed ID: 28442571
[TBL] [Abstract][Full Text] [Related]
18. Isoproterenol induced hypertrophy and associated signaling pathways are modulated by somatostatin in H9c2 cells.
Somvanshi RK; Qiu X; Kumar U
Int J Cardiol; 2013 Aug; 167(3):1012-22. PubMed ID: 22465343
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction.
Pontier SM; Percherancier Y; Galandrin S; Breit A; Galés C; Bouvier M
J Biol Chem; 2008 Sep; 283(36):24659-72. PubMed ID: 18566454
[TBL] [Abstract][Full Text] [Related]
20. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor.
Tepe NM; Liggett SB
J Recept Signal Transduct Res; 2000 Jan; 20(1):75-85. PubMed ID: 10711498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
